Plus Therapeutics Reports Q1 GAAP EPS of -$1.05, Revenue Beats Estimates
Plus Therapeutics (NASDAQ:PSTV) reported a first-quarter GAAP earnings per share loss of $1.05, missing estimates by $0.15. However, the company's revenue came in at $1.03 million, beating expectations by $60,000.
Tickers: $PSTV
Topics: eps_miss financials revenue_beat